<DOC>
	<DOCNO>NCT02669290</DOCNO>
	<brief_summary>The purpose study determine whether multiple gated acquisition ( MUGA ) guide lead placement improve clinical outcome patient need cardiac resynchronization therapy ( CRT ) compare traditional posterolateral leave ventricular lead placement .</brief_summary>
	<brief_title>Use 3-D Blood Pool Scintigraphy Guide Left Ventricular Pacing Lead Placement Patients Requiring Cardiac Resynchronization Therapy</brief_title>
	<detailed_description>Heart failure ( HF ) prevalence five million individual United States . Approximately 25-30 % patient HF due leave ventricular ( LV ) systolic dysfunction prolong QRS . Prolonged QRS duration ( &gt; 120ms ) ECG HF patient associate increased morbidity mortality . Delayed electrical activation LV translate temporal delay ventricular contraction . This referred mechanical dyssynchrony . Patients advance HF , low ejection fraction ( EF ) less 35 % QRS 120ms indicate cardiac resynchronization therapy ( CRT ) . While patient undergo CRT implantation show dramatic improvement HF symptom , 30-40 % HF patient undergo CRT placement show clinical response . The site placement LV lead show important determinant effect CRT . Measurement leave ventricular ejection fraction ( LVEF ) perform use non-invasive measure MUGA . By use available information leave ventricular systolic function investigator plan investigate effect MUGA-guided versus traditional LV lead placement CRT .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<criteria>Male female , 18 year old Must approve indication CRT implantation Must ischemic nonischemic dilate cardiomyopathy Must symptomatic HF New York Association ( NYHA ) Classification III IV Must optimal pharmacological therapy ( include minimum , ACE inhibitor betablocker therapy tolerate . Must leave ventricular ejection fraction ( LVEF ) â‰¤35 % Must ventricular conduction delay manifest QRS duration &gt; 120msec Must able provide inform consent study participation willing comply followup test schedule visit HF diagnosis le 3 month Physical limitation ambulation Life expectancy less six month Pregnant plan pregnancy next 6 month ( must negative pregnancy test 7 day prior enrollment )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>